AMH and ovarian hyperstimulation syndrome: In contrast, the ASRM 2016 guideline on the prevention and treatment of moderate and severe OHSS, found ‘fair evidence’ that serum E2 concentrations, among other factors including elevated AMH levels, multifollicular development and a high number of oocytes retrieved, are associated with an increased risk of OHSS.